HLA-A and cancer: To further strengthen our in vitro analysis13,26, we tested the reactivity of A23 TCR-Ts in a syngeneic, transgenic HLA-A*02:01 mouse cancer model27, allowing us to evaluate the organs of successfully treated mice for T cell-induced autoimmunity.